Über die Bestimmung und Aktivierung des Papains
In: Hoppe-Seyler´s Zeitschrift für physiologische Chemie, Band 295, Heft Jahresband, S. 323-332
5 Ergebnisse
Sortierung:
In: Hoppe-Seyler´s Zeitschrift für physiologische Chemie, Band 295, Heft Jahresband, S. 323-332
In: Notfall & Rettungsmedizin: Organ von: Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin, Band 19, Heft 3, S. 225-236
ISSN: 1436-0578
In: Werkstattstechnik: wt, Band 106, Heft 7-08, S. 488-493
ISSN: 1436-4980
Maschinenhersteller müssen sich neben ihren Maschinen vor allem durch zusätzliche Instandhaltungs- und Wartungsdienstleistungen im Wettbewerb differenzieren. Um diese Dienstleistungen beim Kunden "vor Ort" anbieten zu können, müssen Servicestandorte beziehungsweise -netzwerke geplant werden. Am wbk Institut für Produktionstechnik wurde eine Methodik entwickelt, welche die Instandhaltungsstrategie der Werkzeugmaschinen in der Planung berücksichtigt.
An increasing global competitive pressure makes it essential for machine manufacturers to differentiate themselves from their competitors by additional services. These services are sold together with the machines to form the so called hybrid service packages. Service networks are needed to offer such services. At wbk institute of Production Science a methodology has been developed for planning a service network taking the machines service strategy into account.
Background. The German National Health Interview and Examination Survey (GHS) is the first government mandated nationwide study to investigate jointly the prevalence of somatic and mental disorders within one study in the general adult population in Germany. This paper reports results from its Mental Health Supplement (GHS-MHS) on 4-week 12-month, and selected lifetime prevalence of a broad range of DSM-IV mental disorders, their co-morbidity and correlates in the community. Methods. The sample of the GHS-MHS (n=4181; multistage stratified random sample drawn from population registries ; conditional response rate: 87.6%) can be regarded as representative for the German population aged 18–65. Diagnoses are based on fully structured computer assisted clinical interviews (M-CIDI), conducted by clinically trained interviewers. Results. 12-month prevalence for any DSM-IV study disorder is 31% (lifetime: 43%; 4-week: 20%) with anxiety disorders, mood disorders and somatoform syndromes being the most frequent diagnoses. Retrospective age of onset information reveals that most disorders begin early in life. Comorbidity rates among mental disorders range from 44% to 94%. Correlates of increased rates of mental disorders and co-morbidity were: female gender (except for substance disorders), not being married, low social class, and poor somatic health status. Health care utilization for mental disorders depended on co-morbidity (30% in 'pure', 76% in highly co-morbid cases) and varied from 33% for substance use disorders to 75% for panic disorder. Conclusions. Results confirm and extend results from other national studies using the same assessment instruments with regard to prevalence, co-morbidity and sociodemographic correlates, covering a broader range of DSM-IV disorders [i.e. somatoform disorders, all anxiety disorders (except PTSD), mental disorders due to substance or general medical factor, eating disorders]. Intervention rates were higher than in previous studies, yet still low overall.
BASE
In: Journal of the International AIDS Society, Band 15, Heft S4, S. 1-1
ISSN: 1758-2652
Different diagnostic parameters may affect the tropism prediction reliability. The impact of usage of FPR cut‐offs<20%, use of viral RNA versus proviral DNA samples, single versus triple amplification, and presence of MVC resistance mutations on tropism prediction at baseline were analysed on 101 patients receiving maraviroc (MVC) and correlated with their clinical outcome. This was a non‐interventional, retrospective study. 82 RNA and 54 DNA samples from the 101 patients receiving MVC were obtained. The V3 region was sequenced and the tropism predicted using the geno2pheno[coreceptor] and T‐CUP tools with FPR cut‐offs of 5%, 7.5%, 10%, 15% and 20%. Additionally, 27/82 RNA and 28/54 DNA samples were analysed in triplicate and 34/82 samples with the ESTA assay. The influence of 16 MVC resistance mutations on clinical outcome was studied. The genotypic susceptibility score (GSS) of the concomitant drugs was mapped to numerical values: susceptible to 1 (or 0.5 for NRTIs), intermediate to 0.5 (0.25 for NRTIs) and resistant to 0. Detection of baseline R5 viruses in RNA (by geno2pheno[coreceptor] and T‐CUP) or DNA (by T‐CUP) samples correlated with MVC‐treatment success. Both tools performed very similarly, with PPVs close to 90%, even with FPR cut‐offs as low as 5%. The use of triple amplification did not improve the prediction value but reduced the number of patients elegible for MVC treatment. No influence of the GSS or MVC resistance mutations on the clinical outcome was detected. Genotypic tropism testing from viral RNA and proviral DNA using the geno2pheno[coreceptor] and T‐CUP systems is valid to select candidates for MVC treatment. Our data suggest that the use of FPR cut‐offs of 5–7.5% and single amplification from RNA or DNA would assure a safe administration of MVC without excluding many patients who could benefit from this potent antiretroviral drug.